Leveraging artificial intelligence (AI), Linearis provides a comprehensive health status based on the analysis of 1,400 metabolomic biomarkers through mass spectrometry. The platform will enable its clients to improve prevention, screening, treatment monitoring, and new drug discovery….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.